Prognostic role of early prostate specific antigen changes after [<scp><sup>177</sup>Lu</scp>]<scp>Lu‐PSMA</scp> radioligand therapy of metastasized prostate cancer: A <scp>meta‐analysis</scp>
European journal of clinical investigation